Skip to main content
Top
Published in: Annals of Hematology 1/2022

01-01-2022 | Acute Coronary Syndrome | Original Article

The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction

Authors: Mitchell Davis, Mohammad Reza Movahed, Mehrtash Hashemzadeh, Mehrnoosh Hashemzadeh

Published in: Annals of Hematology | Issue 1/2022

Login to get access

Abstract

Platelets play an integral role in the pathogenesis of acute coronary syndrome (ACS). The purpose of this study was to investigate any correlation between immune thrombocytopenia (ITP) and non-ST segment elevation myocardial infarction (NTSEMI), a common presentation of ACS. Using the large Nationwide Inpatient Sample (NIS) database, we studied any correlation between NSTEMI and ITP utilizing ICD-9 codes. We performed uni- and multivariate analysis adjusting for risk factors from the years 2002–2011. Data was extracted from 106,653 ITP patients and 79,636,090 controls. In multiple years of the study period (2002–2011), NSTEMI incidence was significantly higher in ITP patients when compared with non-ITP patients in the univariate analysis (odds ratio average 1.226). However, no significant association was found after adjusting for additional risk factors in multivariate analysis. Based on our large database study, ITP is not independently associated with NSTEMI incidence after adjusting for comorbidity.
Literature
3.
go back to reference Meyer BJ, Badimon JJ, Mailhac A et al (1994) Experimental myocardial ischemia/infarction: inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy. Circulation 90(5):2432–2438CrossRef Meyer BJ, Badimon JJ, Mailhac A et al (1994) Experimental myocardial ischemia/infarction: inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy. Circulation 90(5):2432–2438CrossRef
19.
go back to reference Zaid G, Dawod S, Rosenschein U (2013) Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management. Isr Med Assoc J IMAJ 15(12):775–776PubMed Zaid G, Dawod S, Rosenschein U (2013) Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management. Isr Med Assoc J IMAJ 15(12):775–776PubMed
23.
go back to reference Jy W, Horstman LL, Arce M, Ahn YS (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119(4):334–345PubMed Jy W, Horstman LL, Arce M, Ahn YS (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119(4):334–345PubMed
28.
go back to reference Takagi S, Suzuki I, Watanabe S (2015) Risk of thromboembolism in patients with immune thrombocytopenia 3(1):9 Takagi S, Suzuki I, Watanabe S (2015) Risk of thromboembolism in patients with immune thrombocytopenia 3(1):9
Metadata
Title
The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction
Authors
Mitchell Davis
Mohammad Reza Movahed
Mehrtash Hashemzadeh
Mehrnoosh Hashemzadeh
Publication date
01-01-2022
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2022
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-021-04668-9

Other articles of this Issue 1/2022

Annals of Hematology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.